Filing Details

Accession Number:
0001209191-17-052501
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-12 19:50:26
Reporting Period:
2017-09-12
Accepted Time:
2017-09-12 19:50:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1377121 Protagonist Therapeutics Inc PTGX Pharmaceutical Preparations (2834) 980505495
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1675878 S. Richard Shames C/O Protagonist Therapeutics, Inc.
7707 Gateway Boulevard, Suite 140
Newark CA 94560
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-09-12 3,687 $14.31 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017.
  2. Includes 1,822 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 8, 2017.
  3. The shares were sold at prices ranging from $14.251 to $14.3443. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.